Lexaria Bioscience Corp. (NASDAQ:LEXXW) Short Interest Update

Lexaria Bioscience Corp. (NASDAQ:LEXXW) saw a large increase in short interest in August. As of August 15th, there was short interest totalling 2,600 shares, an increase of 766.7% from the July 31st total of 300 shares. Based on an average trading volume of 7,100 shares, the days-to-cover ratio is currently 0.4 days.

Lexaria Bioscience Stock Performance

Shares of LEXXW stock traded up $0.03 during mid-day trading on Tuesday, reaching $1.17. 1,419 shares of the stock traded hands, compared to its average volume of 15,012. The stock’s fifty day simple moving average is $1.17 and its two-hundred day simple moving average is $1.17. Lexaria Bioscience has a 1-year low of $0.05 and a 1-year high of $2.50.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.